Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)

Market Cap	1.62B +53.8%
Revenue (ttm)	3.91B -33.0%
Net Income	34.35M -39.8%
EPS	1.19 -42.6%
Shares Out	n/a
PE Ratio	47.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	116,913
Average Volume	100,437
Open	55.06
Previous Close	53.71
Day's Range	54.31 - 56.39
52-Week Range	38.01 - 100.00
Beta	0.80
RSI	40.73
Earnings Date	May 26, 2026

About NSE:AAREYDRUGS

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 132
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AAREYDRUGS

Financial Performance

In fiscal year 2025, NSE:AAREYDRUGS's revenue was 4.74 billion, an increase of 17.73% compared to the previous year's 4.03 billion. Earnings were 40.24 million, a decrease of -14.09%.